These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16132481)

  • 1. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer.
    Gavioli M; Luppi G; Losi L; Bertolini F; Santantonio M; Falchi AM; D'Amico R; Conte PF; Natalini G
    Dis Colon Rectum; 2005 Oct; 48(10):1851-7. PubMed ID: 16132481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.
    Agarwal A; Chang GJ; Hu CY; Taggart M; Rashid A; Park IJ; You YN; Das P; Krishnan S; Crane CH; Rodriguez-Bigas M; Skibber J; Ellis L; Eng C; Kopetz S; Maru DM
    Cancer; 2013 Dec; 119(24):4231-41. PubMed ID: 24089344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery.
    de Campos-Lobato LF; Geisler DP; da Luz Moreira A; Stocchi L; Dietz D; Kalady MF
    J Gastrointest Surg; 2011 Mar; 15(3):444-50. PubMed ID: 21140237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma.
    Bedrosian I; Rodriguez-Bigas MA; Feig B; Hunt KK; Ellis L; Curley SA; Vauthey JN; Delclos M; Crane C; Janjan N; Skibber JM
    J Gastrointest Surg; 2004 Jan; 8(1):56-62; discussion 62-3. PubMed ID: 14746836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interval between neoadjuvant chemoradiation and surgery for the management of rectal cancer.
    Huerta S
    J Gastrointest Surg; 2011 Jul; 15(7):1292; author reply 1293. PubMed ID: 21484481
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors for local recurrence and distant metastasis of mucinous colorectal adenocarcinoma.
    Emile SH; Magdy A; Elnahas W; Hamdy O; Abdelnaby M; Khafagy W
    Surgery; 2018 Feb; ():. PubMed ID: 29361368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with locally recurrent rectal cancer with a previous history of distant metastases: retrospective cohort study.
    Sorrentino L; Daveri E; Belli F; Vigorito R; Battaglia L; Sabella G; Patti F; Randon G; Pietrantonio F; Vernieri C; Scaramuzza D; Villa S; Milione M; Gronchi A; Cosimelli M; Guaglio M
    BJS Open; 2024 May; 8(3):. PubMed ID: 38869237
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
    Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
    Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer.
    Cho IJ; Jeong JU; Nam TK; Kim YH; Song JY; Yoon MS; Ahn SJ; Cho SH
    Oncol Lett; 2023 Jun; 25(6):263. PubMed ID: 37216168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Survival in Complete Pathological Response after Long-Course Chemoradiotherapy in Patients with Advanced Rectal Cancer.
    Ulusoy C; Kamalı GH; Nikolovski A
    Curr Oncol; 2023 Jan; 30(1):1054-1064. PubMed ID: 36661730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer-Systematic Review.
    Smolskas E; Mikulskytė G; Sileika E; Suziedelis K; Dulskas A
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer.
    Jo H; Kim ST; Lee J; Park SH; Park JO; Park YS; Lim HY; Yu JI; Park HC; Choi DH; Park Y; Cho YB; Huh JW; Yun SH; Kim HC; Lee WY; Kang WK
    Cancer Res Treat; 2023 Jan; 55(1):189-195. PubMed ID: 35681110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperfractionation versus Conventional Fractionation of Preoperative Intensity-Modulated Radiotherapy with Oral Capecitabine in Locally Advanced Mid-Low Rectal Cancer: A Propensity Score Matching Study.
    Shi C; Zhang Y; Li Y; Geng J; Zhu X; Wang H; Cai Y; Wang W
    J Oncol; 2022; 2022():9119245. PubMed ID: 35444702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deeper sections reveal residual tumor cells in rectal cancer specimens diagnosed with pathological complete response following neoadjuvant treatment.
    Slumstrup L; Eiholm S; Bennedsen ALB; Jepsen DNM; Gögenur I; Fiehn AK
    Virchows Arch; 2022 May; 480(5):1041-1049. PubMed ID: 35099633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequacy of Surgical Pathology Reports of Colorectal Carcinoma and Its Significance.
    Khan S; Haider G; Abid Z; Bukhari N; Khan SZ; Abid M
    Cureus; 2021 Aug; 13(8):e16965. PubMed ID: 34540379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international survey-based study on colorectal cancer pathology reporting-guidelines versus local practice.
    Urbanowicz M; Grabsch HI; Fiteni F; Liu Y; Caballero C; Fléjou JF
    Virchows Arch; 2018 Dec; 473(6):697-708. PubMed ID: 30255341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System.
    Song C; Chung JH; Kang SB; Kim DW; Oh HK; Lee HS; Kim JW; Lee KW; Kim JH; Kim JS
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30205529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human peripheral blood-derived mesenchymal stem cells with NTRK1 over-expression enhance repairing capability in a rat model of Parkinson's disease.
    Liu K; Zhang W; Li Y; Ding Q; Bai Y; Wang F; Xu G
    Cytotechnology; 2018 Oct; 70(5):1291-1299. PubMed ID: 29978273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer.
    Lim SG; Kim YB; Oh SY
    World J Surg; 2016 Dec; 40(12):3029-3034. PubMed ID: 27464916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    McCluggage WG; Judge MJ; Clarke BA; Davidson B; Gilks CB; Hollema H; Ledermann JA; Matias-Guiu X; Mikami Y; Stewart CJ; Vang R; Hirschowitz L;
    Mod Pathol; 2015 Aug; 28(8):1101-22. PubMed ID: 26089092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.